Optimal Titration Regimen for SBR759 in Lowering Serum Phosphate Levels in Asian Chronic Kidney Disease Patients on Hemodialysis

Inclusion criteria * Men or women of at least 18 years old or 20 years old in Japan. * Stable maintenance of hemodialysis 3 times per week. * Controlled serum phosphate if under phosphate-binder therapy. * Serum phosphate level \> 6.0 mg/dL (\> 1.9 mmol/L) prior to study treatment initiation. Exclusion criteria * Peritoneal dialysis or a non-conventional hemodialysis technique . * Parathyroidectomy or transplant scheduled during the study. * Uncontrolled hyperparathyroidism * History of hemochromatosis or ferritin \> 800 µg/L. * Clinically significant GI disorder * Unstable medical condition other than Chronic Kidney Disease. * Treated with sevelamer HCl monotherapy or SBR759. * Treated with oral iron. * Other protocol-defined inclusion/exclusion criteria may apply.